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Abstract: Lung cancer is one of the malignancies causing deaths worldwide. The yet to be developed non-invasive diag-
nostic techniques, are a challenge for early detection of cancer before it progresses to its later stages. The currently avail-
able diagnostic methods are expensive or invasive, and are not fit for general screening purposes. Early identification not 
only helps in detecting primary cancer, but also in treating its secondaries; which creates a need for easily applicable tests 
to screen individuals at risk. A detailed review of the various screening methods, including the latest trend of breath 
analysis using gold nanoparticles, to identify cancer at its early stage, are studied here. The VOC based breath biomarkers 
are used to analyze the exhaled breath of the patients. These biomarkers are utilized by Chemiresistors coated with gold 
nanoparticles, which are found to be the most suited technique for early detection of lung cancer. This technique is highly 
accurate and is relatively easy to operate and was tested on smokers and non-smokers. This review also gives as an outline 
of the fabrication and working of the device Na-Nose. The Chemiresistors coated with Gold nanoparticles, show a great 
potential in being an non-invasive and cost-effective diagnostic technique for early detection of lung cancer. 
Keywords: Benchmarks, biomarkers, cancer, chemiresistor, endogenous, exogenous, GC-MS system, IMS, monolayer-capped, 
phasetransfer, PCA, SPME, TEM, thiol, VOC. 
INTRODUCTION 
Lung cancer accounts for around 28% of cancer-related 
deaths worldwide [1]. More than 60% of patients have their 
symptoms diagnosed at the later stages with longevity of less 
than 10%. The chances of survival are narrow and at the 
early stages, it cannot be detected due to the presence of little 
or no symptoms. Patients diagnosed during their initial phase 
of lung cancer can live for a period of 5 years [2]. There is a 
need for a new, simple and innovative technique which is 
less expensive and non-invasive. Recent years have brought 
forward a new method for the early diagnosis of Lung cancer 
by the analysis of the exhaled breath which contains blue-
prints of gaseous and nongaseous markers that will help in 
distinguishing the breath of cancer stricken patients from the 
healthy population [3]. 
DETECTION TECHNIQUES 
Symptoms like persistent cough, blood filled sputum, 
pain in the chest, change in the voice pattern and recurrent 
pneumonia or bronchitis are mainly noticed in the last stage 
of lung cancer and the techniques used for its detection and 
diagnosis is expensive. The current techniques used are: 
• Chest X-ray 
Chest X-ray cannot be used in the detection of lung tu-
mours in their earliest stages. Coincidentally around 10% of 
lung cancer cases are discovered only when people undergo 
a chest X-ray for other respiratory conditions. Fig. (1) shows 
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a chest X-Ray of normal lungs and another chest X-ray 
pointing to an abnormal mass present inside the lungs. 
 
 
Fig. (1). Chest X-Ray of normal lungs and cancer affected lungs 
[7]. 
 
• Sputum Cytology 
Sputum contains lung cells, which can be analysed under 
the microscope using sputum cytology. This test can reveal if 
the lung cells have fully developed into cancer cells or not. 
• Pulmonary Function Tests (PFT)  
PFT is used to measure the amount of air taken in and re-
leased out by the lungs. Since Lung cancer constricts the 
flow of air in and out of the lungs, it transfers poor amount 
of oxygen into the blood, thus aiding in lung cancer detec-
tion. 
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• Chest Tomography 
After the patient is diagnosed by chest X-ray, further ex-
amination of lung tissues is done using CT, which gives an 
indication whether the cancer is present in the lungs or has 
spread to the other parts of the body. 
• Bronchoscopy with Biopsy 
Examination of the interior region of the lungs can be 
done using a bronchoscope and a biopsy of a lung nodule or 
mass taken. This technique can be uncomfortable for one to 
undergo and the assessment of the biopsied tissue is expen-
sive [3-6]. 
HISTORY OF BREATH ANALYSIS 
Since ancient times, physicians have known that a per-
son’s breath gives an indication of one’s health conditions. 
For example, people with diabetes have a ‘fruity’ smell and 
people with kidney disease have a fish-like smell to their 
breath [8], which has lead to researchers in discovering its 
potential as a diagnostic tool. Collection of a breath sample 
is much safer and easier compared to that of collecting blood 
samples or urine samples [9, 10] and the compounds present 
in the breath can be detected and correlated to various dis-
eases. VOCs as illustrated in Fig. (2), for lung cancer were 
first found by Gordon and colleagues in 1985, using Gas 
Chromatography-Mass Spectrometry (GC-MS) [11]. 
BIOMARKERS 
National Institute of Health states that a biomarker is an 
indicator of any normal biological, pathogenic or pharma-
cological responses that take place in the human body. These 
biomarkers are present in various regions of the human body 
such as, the cells of the tumor growth, fluids in the body 
which include blood, urine, cerebrospinal fluid, sputum, sa-
liva, and breath. Their discovery, will lead to a non-invasive, 
early detection of a few types of cancer [12]. This has 
opened up a new beginning for the early diagnosis of cancer 
and the precise delivery of drugs to the specific cancer re-
gions of the human body [13]. 
The surface of cancerous tissue emits chemicals in the 
form of Volatile organic compounds (VOCs) which can be 
detected by sensors (chemiresistors) on a Nano-sensor array. 
These sensors can differentiate between the breath of a 
healthy and cancerous individual. This forms the foundation 
for a fast, accurate method for detection of cancer [13, 14]. 
 
 
Fig. (2). VOC [22]. 
VOC 
The exhaled breath is made up of oxygen, carbon diox-
ide, nitrogen, water, inert gases and volatile substances. 
These volatile substances can be produced endogenously or 
exogenously. The endogenous breath biomarkers for lung 
cancer are described in Table 1 [15]. 
 
Table 1.  Types of VOCs [36]. 
Class of VOC Example 
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Around 42 VOCs represent lung cancer VOC biomark-
ers, out of which the important VOCs are: 
• Acetaldehyde (below 2-10 ppb)  
• Formaldehyde (below 2-10 ppb)  
• Undecane (24+4 ppb)  
• Isopropene (72.9- 81.5 ppb)  
• Methanol (below 118.5 ppb) 
• Ethylbenzene (145+35 ppb)  
• Acetone (below 458.7 ppb)  
The Exhaled Breath VOC Analyzers can be further used 
in the early detection of breast cancer by the detection of 
VOC biomarkers that include the derivatives of alkanes such 
as tridecane, hexanal, heptanal, tetradecane and dodecane 
[16, 17]. Formaldehyde is also found in breast, bladder, and 
prostate along with 16 other compounds such as toluene; 
acetic acid; 2,3,4-trimethyl decane; p-xylene; and 2,2-
dimethyldecane dodecane; 3,3-dimethyl pentane; 1- io-
dononane; etc [18-21].  
EXHALED BREATH VOC ANALYZERS 
The Exhaled breath VOC analyzers are devices used for 
the detection of the VOCs, whose abnormal levels point to 
the presence of cancer in the human body. These devices 
have to be fine-tuned by validating the biomarkers with re-
spect to their pure compounds to achieve high sensitivity, 
specificity and accuracy for them to be used as a screening 
tool for the early detection of lung cancer [23]. Following 
are the types of VOCs analyzers under trial, as screening tool 
of lung cancer detection. 
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GC and Mass Spectrometry (GC-MS)  
GC-MS system is versatile in determining a wide range 
of VOCs [6]. Gas chromatograph has a high separating effi-
ciency [24] and separates the chemical mixture into pulses of 
pure chemicals based on their volatility, or ease with which 
they evaporate into a gas. The MS identifies the VOCs and 
quantifies them based on their structure [25]. 
Electronic Noses  
In the Electronic nose (E-Nose) as portrayed in Fig. (3), 
the VOCs adsorb onto a sensor where a change in conductiv-
ity, color or oscillation of a crystal is detected by the sensing 
system of the E-nose. The E-nose responds to only a mixture 
of compounds in the sample. The pattern recognition system 
interprets and detects the high levels of VOCs causing Lung 
cancer [10, 17, 26-28]. The drawbacks include the extensive 
preparation of the breath samples, lack of quantitative data and 
calibration [17, 29]. 
Quartz Microbalance  
Quartz microbalance [30] contains piezoelectric sensors. 
These sensors use highly sensitive quartz crystals for the 
measurement of the mass and viscosity of the VOCs that 
interact within its thin films. Molecular interaction between 
target and ligand is detected by the sensor. The resistance at 
resonance, changes with the viscosity of the VOCs in contact 
with the crystal surface, which leads to a frequency shift  
[31-33]. Difficulty lies in the selection of sensitive polymers 
for their application as thin films over the sensors and also in 
the control of the repetition of the coating process [17, 34]. 
Colorimetry 
The colorimeter [35] distinguishes among the VOCs by 
its composite response. The Colorimetry sensor array uses a 
diverse range of chemically responsive dyes. 
Adsorption of VOCs causes these dyes to change their 
colours depending upon their chemical environment which is 
then scanned and converted to a number [17, 36]. 
Ion Mobility Spectrometry (IMS)  
The IMs consists of an ionizing source that breaks the 
VOCs molecules into ions. The detection process in the IMS, 
operated in the positive and negative modes, is based on the 
movement of ions in a drift gas that occurs at the ambient 
pressure under the influence of stable electric field, in the 
range from 100 to 350 Vcm
-1, 
towards a Faraday plate [38], 
thus generating an electrical signal. The electrical signals 
from each VOC combine to produce an ion spectrum [17,  
38, 39]. 
Cyranose 320  
Cyranose 320 consists of 32 carbon polymer sensors that 
respond to exhaled breath, where a change in sensor resis-
tance is caused by the adsorption of the VOC mixtures of the 
breath onto the sensors. The exhaled breath sample of each 
individual results in a pattern of sensor responses, which is a 
characteristic of each individual’s smell print. This helps in 
distinguishing between the breath of a healthy individual and 
of a cancer stricken person [39]. 
 
Fig. (3). Working of electronic nose [37]. 
 
The screening techniques described above aren’t cost-
effective and are slow. They require the use of complex in-
struments for the dehumidification of the breath biomarkers. 
Many of these techniques are difficult to use, thus creating a 
need for highly experienced analysts for the operation and 
the interpretation of the results [17]. This creates a need for 
less complicated breath analysers as shown in Fig. (4), that 
are highly effective for the mass screening of individuals for 
lung cancer. 
NANO-NOSE 
Nano-Nose analyses the gases present in the breath and 
identifies those gases that stipulate the presence of lung can-
cer. It works by binding gases to specific chemiresistors 
coated with gold nanomaterials, thus aiding in the detection 
of volatile organic compounds (VOC) of the exhaled breath. 
CHEMIRESISTORS USING GOLD NANOPARTI-
CLES 
Researchers throughout the world are working on a revo-
lutionary device to detect lung cancer and other types of can-
cers, using exhaled breaths of the patients. A few scientists 
have developed a device containing a carbon-based sensor 
embedded with gold nanoparticles [40]. 
Mono-layered Gold Nanoparticles 
Gold nanoparticles are highly sensitive in the detection of 
biomarkers at lower concentration levels [41]. They are fully 
biocompatible [42] and no scattering occurs when mono-
layered gold nanoparticles are used. All interactions with 
respect to the gold particles occur at the surface. The electron 
density change in the surface causes a maximum shift in the 
surface Plasmon absorption, which helps in the detection of 
VOCs. It thus enables the use of noble metal nanoparticles as 
sensitive sensors [43]. 
Mono-layered capped gold nanoparticles are thermally 
air stable of reduced dispersity, have well controlled size and 
are well spaced [1, 44]. As the concentration of gold 
nanoparticles increases, there is an increase in the dc conduc-
tivity. When the concentration reaches to a moderate level, 
the value of the dc conductivity becomes steady. Toluene 
solvent suspensions and Gold nanoparticle/chloroform are 
used in the preparation of Mono-layered gold nanoparticles 
as there is an increase in electrical conductivity due to the 
presence of shorter molecular chain at the end of the Au 
nanoparticles [45]. These monolayered Au particles control 
the properties at interface and have a high surface area-to-
volume ratio, which makes them different and much better 
Early Detection of Lung Cancer Using Nano-Nose The Open Biomedical Engineering Journal, 2015, Volume 9    231 
than the bigger Au molecules. The limit of identification of 
VOCs by the nanoelectrode is lower than their detection at 
the macrosized electrode. This is mainly due to the presence 








The electrodes present in the Chemiresistors, are coated 
with a conducting polymer film. The thin electrically- 
conductive polymer films swell due to the chemical reaction 
of the volatile organic chemicals with that of the films, thus 
causing a change in electrical resistance across the film. The 
chemiresistor can be used repeatedly as it regains its original 
condition by the release of the chemicals in the environment 
[48]. 
METHODS OF PREPARATION (REVIEW) 
Synthesis of Monolayer-capped Gold Nanoparticles 
(MCNP) 
Metallic nanoparticles are synthesized in a two-phase 
system which is composed of aqueous and non-aqueous so-
lutions. These solutions are combined with techniques of 
extraction of ions. The metallic monolayered nanoparticles 
are then coated with a hydrophobic layer of alkanethiols. 
First the ions from an aqueous solution are transferred with 
the help of a phasetransfer reagent to a toluene solution. 
Then the reduction of gold is done with an aqueous borohy-
dride solution which is later capped with thiols [44]. Lastly 
the gold nanoparticles are repeatedly extracted and purified 
from thiols [1].  
Sensor Array Patterning and Fabrication 
As shown in Fig. (5), fourteen different chemiresistive 
MCNP films deposited on micrometric electrical transduc-
ers, are combined onto a sensor array. They are insensitive to 
the water molecules in the exhaled breath and are placed 
inside a test chamber [49]. Deposition of 20 circular gold 
electrodes on thermal oxide silicon wafer is done by the use 
of an electron beam evaporator. Post-deposition, the gold 
nanoparticles are then extracted from their chloroform solu-
tion by sonication [1]. 
Breath Testing 
The sensor array is first tested by evacuating the chamber 
and exposing it to a mixture of artificially designed VOC 
biomarker breath patterns. The procedure is repeated and the 
signals obtained, are scrutinized using a standard PCA algo-
rithm [1, 49]. 
 
Fig. (5). Schematic representation of lung cancer breath testing 
using sensor array containing monolayered gold nanoparticles. (a) 
Chemiresistor array, (b) and its SEM image, (c) SEM image of Au 
nanoparticles on the sensor array (d) with its transmission electron 
micrograph (TEM) image (e, f, g) electronic testing of breath [1]. 
 
Principal Component Analysis (PCA) 
Analyzing the relationship between multiple variables 
within a multi-dimensional data, requires a statistical method 
such as PCA, which can reduce the dimension of the data 
using linear feature extraction technique. Each sensor data is 
retained and arranged into a matrix format where the sensor 
types are arranged in rows and the measurement numbers are 
arranged in columns. The percentage-resistance changes and 
slopes are used in the calculation of the covariance matrix 
and its values of the Eigenvector and Eigen value. The two 
principle components discriminate between non-overlapping 
healthy and lung cancer group. This is used in the interpreta-
tion of PCA results, in the score plot containing the projection 
of two cluster data onto the two dimensional planes [40]. The 
data is then confirmed by testing the breath patterns using 
Solidphase Microextraction (SPME) and GC-MS. 
A COMPARISON OF EXHALED BREATH ANALYZ-
ERS  
The highly sensitive and accurate GC-MS, with 87% 
reproducibility, are rarely used because they are expensive, 
difficult to use and require highly experienced analysts to 
operate them and interpret the results [1, 17].  
Electronic nose cannot obtain quantitative data as the 
sensors are not selective. If more than one type of vapour is 
present, a quantitative output from one sensor is likely to be 
erroneous [50] and therefore the device cannot be calibrated.  
Quartz microbalance gives an accuracy of 80%, sensitiv-
ity of 85% with 100% specificity. Their main drawback lies 
in the stability and precision due to the requirement for the 
pre-concentration of the breath samples collected [51, 52]. 
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The sensitivity of the Colorimeter is 73.3% and specific-
ity 72.4%. They are generally less preferred due to their low 
sensitivity and the inability to work in the presence of hu-
midity and the need for the pre-concentration of the collected 
breath [17]. 
The accuracy of Cyranose 360 is 85% but is not used as 
it’s slow, costly, requires complex instruments and cannot 
detect VOCs in the presence of humidity [17]. 
The electronic nose containing chemiresistors coated 
with gold nanoparticles have an accuracy of around 88%. 
The long chain thiols used in the synthesis of the monolay-
ered gold particles differ in their polarity and vapor pressure. 
This provides good stability to the device for a period of 
three months [54]. Change in the electrical resistance of the 
film occurs due to the absorption of the breath onto the sen-
sor array. As a result, these chemiresistors can identify the 
pattern of each breath biomarker and therefore quantitative 
data can be obtained [51]. Pre-concentration of the breath 
samples is not required due to the hydrophobic nature of the 
thiol coating on the Au nanoparticles. It has a greater repro-
ducibility of 90%, which proves that is more accurate, prom-
ising and convenient to be used as a method for lung cancer 
detection at its early stages [1]. 
The advantages of this technique include a high accuracy 
in discriminating between malignant and benign disease. The 
breath analysis test can be repeated in short intervals, with-
out the requirement for dehumidification. Large volume of 
sample can be collected and the test is easy to perform. It can 
be tested on smokers as well as non-smokers and has a great 
potential as a screening test. The limitations of exhaled 
breath analysis include the lack of recommended guidelines 
for sampling of exhaled breath. Also a need arises, to bring 
down the cost of the gold nanoparticles. Collection and 
analysis of the samples using techniques such as mass spec-
trometry and infrared spectroscopy also hinder in the faster 
analysis of the breath biomarkers. 
CONCLUSION 
For the early detection of lung cancer, standard diagnos-
tic techniques cannot be used as they detect abnormalities at 
the later stages. An innovative, portable technique is required 
for the early detection of lung cancer. VOC biomarker test-
ing in the samples of exhaled breath is a non-invasive ap-
proach. Nanotechnology can be used in the development of a 
simple, portable and effective screening device for lung can-
cer, as the surface area of the nanoparticles is high, making 
them more suitable as breath biomarkers. A Chemiresistor 
uses monolayered gold nanoparticles for being biocompati-
ble and their ability to detect VOCs at very low concentra-
tions. A much greater potential exists if this technology can 
be used to diagnose other types of cancer, which could mean 
enhanced opportunities to save lives [1, 53] and [14]. 
FUTURE SCOPE 
Breath analysis complements blood and imaging tech-
niques is the future of medical testing, making it suitable for 
the early detection of lung cancer. There are broader applica-
tions of this technology wherein the breath biomarkers pre-
sent in exhaled breath can also be used in the detection of 
colon cancer, breast cancer, rectal cancer and bladder cancer. 
The discovery of these revolutionary electronic and chemical 
sniffers by the scientists will help in the examination of the 
exhaled breath for signs of other maladies such tuberculosis, 
asthma and other types of cancer. 
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